Chemed Corporation (CHE) Hit 52-Week High at $332.05 on May, 16

May 16, 2018 - By Mark Babin

Big Money Sentiment decreased to 0.96 in Q4 2017. It has change of 0.08, from 2017Q3’s 1.04. The ratio worsened due to Chemed Corporation positioning: 18 sold and 94 reduced. 49 funds took positions and 58 increased positions. Investors holded 15.40 million in 2017Q3 but now own 14.86 million shares or 3.45% less.
Wells Fargo And Mn reported 79,653 shs or 0.01% of all its holdings. Tompkins Financial Corp stated it has 0.03% of its capital in Chemed Corporation (NYSE:CHE). Amer stated it has 0.01% in Chemed Corporation (NYSE:CHE). Ubs Asset Americas Inc holds 0% of its capital in Chemed Corporation (NYSE:CHE) for 9,362 shs. Hanson Doremus Invest Mngmt has invested 0.59% in Chemed Corporation (NYSE:CHE). Apg Asset Nv accumulated 0.01% or 34,400 shs. Smith Asset Management Grp Ltd Partnership reported 19,526 shs stake. Barclays Public Ltd Liability Corp owns 0% invested in Chemed Corporation (NYSE:CHE) for 14,562 shs. Shell Asset owns 10,315 shs or 0.05% of their US capital. Eulav Asset Mngmt owns 32,000 shs or 0.37% of their US capital. Eqis Capital Management reported 0.06% stake. State Of Alaska Department Of Revenue holds 0.02% or 3,189 shs. Pub Employees Retirement Of Ohio holds 0% or 1,059 shs in its capital. Parametrica Management Ltd invested 0.24% of its capital in Chemed Corporation (NYSE:CHE). Fmr Limited Liability Company holds 0.02% or 702,407 shs.

Chemed Corporation had 13 insider sales and 0 insider purchases since January 12, 2018. This’s net activity of $27.86 million. On Friday, January 12 Shares for $117,485 were sold by SAUNDERS DONALD E. Another trade for 300 shs valued at $91,476 was sold by Dallob Naomi C. On Wednesday, April 25 $428,257 worth of Chemed Corporation (NYSE:CHE) was sold by LEE SPENCER S. Witzeman Michael D also sold $313,000 worth of Chemed Corporation (NYSE:CHE) shs. 10,000 shs were sold by WILLIAMS DAVID PATRICK, worth $3.16M on Monday, May 7. The insider Westfall Nicholas Michael sold 12,919 shs worth $4.04M.

Today Chemed Corporation (NYSE:CHE) with $332.05 stock price, reached yearly high with $355.29 PT or 7.00 % above. On May, 16 it was reported by Barchart.com. Chemed Corporation (NYSE:CHE) has $5.29B MC. At $355.29 PT, the company’s valuation could be $370.44M more.

Ticker’s shares touched $332.05 during the last trading session after 1.72% change.Chemed Corporation has volume of 105,172 shares. Since May 16, 2017 CHE has risen 48.33% and is uptrending. The stock outperformed the S&P 500 by 36.78%.

On July, 24 Chemed Corporation (NYSE:CHE)’s earnings release is awaited by WallStreet, according to Faxor. Last year’s earnings per share was $2.15, while now analysts expect change of 24.65 % up from current $2.68 earnings per share. If the current earnings per share of $2.68 is accurate, CHE’s profit could hit $42.71M. -1.47 % negative EPS growth is what Wall Street’s predicts after $2.72 reported EPS last quarter.

More recent Chemed Corporation (NYSE:CHE) news were announced by Benzinga.com, Globenewswire.com and Seekingalpha.com. The first one has “Earnings Scheduled For April 19, 2018” as a title and was announced on April 19, 2018. The next is “VITAS HEALTHCARE JOINS AMERICAN HOSPITAL ASSOCIATION” on May 07, 2018. And last was announced on April 20, 2018, called “Chemed’s (CHE) CEO Kevin McNamara on Q1 2018 Results – Earnings Call Transcript”.

Chemed Corporation provides hospice and palliative care services in the United States.The firm is worth $5.29 billion. It operates through two divisions, VITAS and Roto-Rooter.The P/E ratio is 56.66. The firm offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers.

Chemed Corporation (NYSE:CHE) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: